Delirium is defined as an acute confusional state with a disturbance of consciousness and a change in cognition which is fluctuating and self-limited in the vast majority of the cases. It is common in intensive care, most frequently in its hypoactive manifestation, and is associated with increased morbidity and mortality. This article reviews the pathogenesis, risk factors, diagnostic assessment, prevention and management of delirium.
Introduction
Delirium is an outward manifestation of brain dysfunction. It is an early sign of acute illness and is the commonest neuropsychiatric condition seen in hospital inpatients. Patients who develop delirium are more likely to suffer worse outcomes than predicted from their admitting illness, including long-term cognitive impairment, acquired dementia and mortality. 1, 2 The syndrome of delirium is defined in the Diagnostic Statistical Manual of Mental Disorders, 4th edition (DSM IV), as an acute confusional state consisting of a disturbance of consciousness (more specifically, the inability to focus, sustain or shift attention) which is accompanied by a change in cognition, such as reduced memory, disorientation, or a perceptual disturbance, perhaps manifesting as hallucinations. Importantly, these changes are acute and fluctuating (in hours to days) in nature. In addition, there is evidence that these changes are a result of a general medical condition or related to drug intoxication or withdrawal.
Lessons from history
Hippocrates first described delirium using the terms phrenitis (frenzy) and lethargus to describe the acutely confused patient. He was more aware than many clinicians today that delirious patients are not necessarily agitated and combative. The majority of patients with delirium have a mixture of symptoms, but usually present with lethargic confusion and psychomotor retardation, so-called 'hypoactive' delirium. 3 The Roman Celsus, in his encyclopaedia De Medicina, which was used as a source of ancient wisdom well into the 15th century, employed the word 'delirium' for the acutely confused state. It literally means 'going off track' or 'out of the furrow.' Clinicians today show a reluctance to commit the word 'delirium' or 'delirious' to patient records, being more inclined to describe a patient as 'appearing confused,' 'not making sense' or 'rambling.'
Outcomes
The development of delirium during hospitalisation is a strong independent marker for a high risk of mortality, not just in hospital patients but for at least 11 months after admission. 4 Among older medical patients, the presence of delirium is associated with a doubling of the risk of dying over the following 12 months, compared to patients without delirium. The risk is highest in the first month and is raised consistently throughout the following 12 months.
As many as six out of 10 patients who survive critical illness struggle with significant cognitive impairment for months to years after their intensive care unit (ICU) stay. 5 The duration of an episode of delirium has been shown to be an independent predictor of cognitive impairment. In mechanically ventilated patients, an increase in the duration of delirium from one day to five days was associated with an almost 5-point decline (one-half Standard Deviation decline) in the mean score from a battery of cognitive tests. At 12 months, the decline in the cognitive score was almost seven points. Clearly, acquired dementia can greatly reduce quality of life, increase healthcare costs and lead to institutionalisation. 6
Pathogenesis
There are currently a number of theories regarding the pathological changes in the brain that result in, and equally from, delirium. These include neuro-inflammatory changes 7 with microglial activation, which is caused by tumour-necrosis factor TNFα; impaired oxidative metabolism; an aberrant stress response; 8 altered cerebral blood flow; increased blood-brain barrier permeability and hypothalamic-pituitary-adrenal axis dysfunction. 9 It is likely that a combination of these possible causes of delirium will prove to be true. A dominant theory, which would explain the common features of delirium caused by many disparate medical conditions, is that a final common pathway of neurotransmitter imbalance is responsible. A number of neurotransmitters have been implicated. The resultant state from this pathway is thought to be due to decreased cholinergic activity. In Alzheimer' s disease and dementia, the basal forebrain cholinergic system shows significant degeneration. It has also been shown in animal models that chronic cholinergic hypofunction increases susceptibility to acute cognitive deficits induced by systemic inflammation. 10 Recently, there has been a focus on the role of serotonin, incorporated into a theory that delirium is caused by tryptophan deficiency. 11 Most recently, the sigma-1 receptor has come under scrutiny, which has been shown to influence the activity of dopamine, acetylcholine and glutamate. 12 The pathogenesis of delirium may also have a genetic component that involves the Apolipoprotein E epsilon 4 allele. Current research, however, reveals there are both positive and negative data for this association. 13, 14 Future studies will likely cast light on the relative influence of inflammation and/or neurotransmitter imbalance.
Risk factors
The incidence of delirium increases with the number of risk factors any one patient has. 15 Risk factors can be either predisposing or precipitating, and modifiable or nonmodifiable. The National Institute for Health and Clinical Excellence (NICE) 16 has collated them recently (see Figure 1 ). A history of cognitive impairment is the most consistent, nonmodifiable risk factor in all delirium studies. 17 A relatively minor precipitating factor may generate a delirious episode in a patient with a multitude of predisposing (vulnerability) factors. 18 However, in patients with no, or few, predisposing factors, a large precipitating factor(s) is required to trigger delirium. Hence, a vulnerable patient who is elderly and has cognitive impairment may develop delirium with an ailment as minor as a urinary tract infection.
There are multiple risk factors for the development of delirium in a hospital setting. These include: current hip fracture, cognitive impairment, age over 65, increased illness severity, sensory impairment (especially of vision or hearing), dehydration, malnutrition, electrolyte imbalance and the use of certain pharmacological agents. 19 Indeed, in residents of a care home, a mini-mental state examination (MMSE) score of less than 10 at baseline has been shown to harbour a much higher risk of developing delirium (33.3%) compared with patients with MMSE scores >10 (3.4%) (a score of 25/30 is normal). 4 For intensive care, van den Boogaard et al have developed the PRE-DELIRIC prediction model to assess adult patients on admission to ICU for the likelihood of developing delirium, using parameters readily available within the first 24 hours of admission, eg urea concentration, Acute Physiology and Chronic Health Evaluation (APACHE-II) score, metabolic acidosis, use of sedatives. 20 Risk factors that confer the highest risk are coma of any cause, use of sedatives and the presence of infection.
Epidemiology
In hospitals, the prevalence of delirium ranges from 15-24% on admission, while the incidence of delirium arising during admission is 6-56%. 20 Overall, this translates to an average of 100 delirious patients in an acute general hospital of 1,000 beds. Patient groups with a high prevalence of delirium include palliative care patients (around 50%) and older patients with dementia admitted for fractured neck of femur (26-56%) 18, 22 . Delirium is common following a stroke (19-33%) and much higher following middle cerebral artery infarct, where delirium is often the presenting feature. 23 The highest prevalence of delirium is seen in the intensive care unit. On admission to ICU up to 30% of patients will have delirium 24 and it is reported in the USA that up to 80% of mechanically ventilated patients may develop delirium at some point during their ICU stay. 17, 25 While the evidence-base is much smaller in the UK, studies and audits consistently show that approximately two out of three sick, ventilated ICU patients will develop delirium at some point during their ICU admission. The incidence of delirium is increased with severity of illness, by around 5% per incremental increase in APACHE score. 24, 26 In critically ill patients with burns, data regarding the specific prevalence of delirium are more limited. One study of delirium in this group of patients revealed a prevalence of 77% with a median duration of three days. 27 These researchers showed that the sedative and analgesic drugs that are routinely used in ICU can be both causative of, and protective against, delirium. This is consistent with observations of other patient groups. 28, 29 In another small study in burns patients, the incidence of delirium was reported to be 31%. 30 It was also found that, of 10 delirious patients, seven had a total body surface area (TBSA) burn of more than 30%, 30 further supporting a correlation between delirium and severity of illness.
In the postoperative period, the incidence of delirium varies widely, depending on the type of surgery and the demographics of the different patient groups. One review of 80 primary datacollection studies on postoperative delirium reported an average incidence of 36.8% 31 with a range of 10-70%. There is high incidence of delirium reported following orthopaedic and cardiac surgery, in particular patients who have undergone prolonged cardiopulmonary bypass. 32 Outside hospital, the prevalence and incidence of delirium in elderly residents in nursing care and residential care homes is not well known. A recent study in the Netherlands reports that prevalence of delirium was 8.9% in nursing homes and 8.2% in residential homes. 33 However, estimates vary depending on diagnostic criteria used and can increase to as much as a third (31.8%) of residents returned to nursing homes following acute hospitalisation. 34 What is clear from the wide range of reported incidences of delirium is that it is either variable in presentation or that the definition and diagnosis are variable.
Modifiable
Non-modifiable 
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Delirium is a clinical syndrome diagnosed at the bedside. It requires an interaction with the patient in which consciousness and thinking can be assessed. Consciousness, in this context, refers to arousal and cognition, ie awareness and the ability to make sense of the environment. Inattention is a key feature of delirium and is perhaps the most difficult to assess. A patient who is orientated in place and time may still have inattention. Clinicians need to actively look for delirium because it can be easily missed. Studies have consistently demonstrated that general ward and intensive care clinicians will miss delirium 70% of the time. 35, 36 Delirious patients can obey direct commands and will usually answer yes to every question, hence asking a patient to stick out their tongue and asking a question that the patient nods to answer, is not an adequate assessment of mental status.
Motoric symptoms
There are three ways that delirium can present based on motoric symptoms. 3 The most common of these is hypoactive delirium, characterised by a quiet, often compliant, very still patient who constantly falls asleep. It is often mistaken as purely due to the effects of sedation (rather than caused by sedation), or depression. 37 While particularly challenging to diagnose due to symptom overlap, hypoactive delirium can be distinguished from depression by judicious use of screening tools. 38 The least common delirium subtype is the hyperactive patient who is combative, agitated and seemingly awake for days on end. Hyperactive delirium is certainly the easiest to recognise, most difficult to manage and as such is the most familiar; however, fewer than 5% of patients will have purely hyperactive delirium. The third type of delirium is a mixed presentation of these two extreme forms. Patients oscillate between the two states or demonstrate a mixture of hypoactive and hyperactive features fluctuating within a very short space of time, even within the duration of a short conversation.
Ward assessment
There are a number of assessment tools that have been developed to help diagnose delirium, ranging from the full goldstandard DSM-IV criteria assessment, which can take up to 40 minutes, to the Single Question in Delirium (SQiD): 'Do you think your relative/friend has been more confused lately?' (sensitivity 80%, specificity 71% compared with psychiatrist interview). 39 Most record several clinical features of delirium that can either be scored or use an algorithm to determine a diagnosis. All the tools vary in the population in which they have been validated, their ease of use, their sensitivity and their specificity. The fact that more delirium screening tools are being developed and that older instruments are still being adapted is an indication of how challenging it can be to diagnose delirium. A selection of the more commonly used assessment instruments is discussed below; however, a comprehensive outline of ward assessment is beyond the scope of this review.
The most widely validated assessment instrument is the Confusion Assessment Method (CAM) developed in 1990 by Inouye et al. 40 This tool has emerged as a standard due to its simple algorithm and reported low inter-rater variability.
However, the CAM, while widely used in delirium research, has proved to be less useful for routine use, due to the training required. Laurila suggested that while it is an acceptable screening instrument, it needs trained physicians to administer it if it is to be a good diagnostic test. 41 Notwithstanding, an averaging of 12 studies demonstrated that the CAM had a sensitivity of 86% and specificity of 93%. 37, 42 The Delirium Rating Scale -revised 1998 (DRS-R98) 38 and the Memorial Delirium assessment Scale (MDAS) 43 are two bedside instruments that have been designed to assess severity of delirium. DRS-R98 is a clinician-rated scale using three diagnostic items and 13 severity items in a 16-item scale, but it requires expertise in evaluating psychiatric phenomenology (sensitivity 92%, specificity 85%). 38 MDAS assesses 10 items including psychomotor activity, perception and attention disturbances and impaired digit span (asking a patient to repeat a short series of numbers forwards and backwards) (sensitivity 92%, specificity 92%). 43 Both rating scales have been validated against other delirium test scales and are able to reliably distinguish delirium from psychiatric conditions including dementia, depression and schizophrenia.
The Nursing Delirium Screening Scale (NuDESC) is a rapid screening tool that does not require direct patient contact. It looks for five features: disorientation, inappropriate behaviour, inappropriate communication, illusions/hallucinations and psychomotor retardation (sensitivity 83%, specificity 81%). 44
Critical care assessment tools
The CAM has been successfully developed for use in ICU. The Confusion Assessment Method for ICU (CAM-ICU) has been validated in a number of studies for intubated patients. 45 The CAM-ICU is a point-in-time, didactic, non-verbal assessment. A patient is tested for inattention by seeing if they can squeeze a hand correctly on the letter A in a series of 10 letters, and for disorganised thinking with four simple yes/no questions and a command (sensitivity 81%, specificity 96%). 19 The Intensive Care Delirium Screening checklist (ICDSC) was validated for intubated patients around the same time, and relies on the detection of seven features of delirium over the course of a nursing shift. 25 The presence of four or more equates to a diagnosis of delirium. Unlike the CAM-ICU, decreased level of consciousness does not count if the patient is on sedatives. It is more subjective than the CAM-ICU, allows the nurse to decide if inattention is due to sedative effects rather than delirium and can diagnose sub-syndromal delirium (sensitivity 99%, specificity 64%). 25 When assessed in the same study, both CAM-ICU and ICDSC perform comparably; however, the CAM-ICU is a better predictor of outcome. 46 These two instruments are less useful outside ICU. 47 All these instruments are easy to complete and are relatively fast. It is not so important which delirium screening tool an intensivist uses so much as actually using one, and using it regularly during the patient' s ICU admission. Simple cognitive screening at point of admission to hospital is also to be recommended.
Management
The mainstay of initial management remains identifying and treating the underlying cause or combination of causes. To this effect, the authors suggest that if there is uncertainty in diagnosis between delirium and other mood disturbances, eg depression, it would be useful to involve a psychiatrist.
Non-pharmacological interventions
Rather than any single factor, multiple predisposing and precipitating factors appear to combine to tip the balance towards a patient developing delirium. Inouye et al demonstrated that targeting reversal of a number of risk factors, ie providing activities for cognitive stimulation and reorientation, early mobilisation, promoting sleep, optimising communication with use of spectacles and hearing aids, together with implementing early fluid resuscitation, could reduce delirium to 9.9% (control rate was 15%). 48 Unfortunately, the intervention had no effect on the severity of any developing episode of delirium. This highlights the importance of prevention of delirium. NICE guidelines 41 recommend that all ICU patients should be screened, and have recommended a delirium prevention strategy, which is summarised in Table 1 . If identified, delirium needs to be managed even if the clinician decides not to treat it.
Hip fracture patients
The involvement of a multidisciplinary team including a geriatrician in the perioperative care of elderly patients helps to decrease incidence of delirium. A randomised trial comparing post-hip fracture repair patients receiving geriatric consultant multicomponent daily review (optimisation of oxygen therapy, electrolytes, nutrition, bowel/bladder function among others) with a non-intervention (reactive, rather than proactive care) group demonstrated that a geriatrician review prevented delirium by over one-third (32% of cases in the intervention group vs 50% cases in the control care group). 49 A recent Dutch study has replicated these data. 50 The number of cases of severe delirium was also reduced by 50% by the intervention; however, there was no difference in duration of delirious episode between the two groups, 49 again emphasising the importance of primary prevention. Pethidine (meperidine) must be avoided in these patients, as it is consistently associated with increased risk of delirium. 51 Geriatrician involvement is essential for patients with fractured neck of femur but this may not be as relevant for ICU patients.
Using light intra-operative sedation may also prevent delirium. A randomised, controlled study of elderly patients undergoing spinal epidural for hip fracture repair demonstrated a 50% reduction in delirium following light propofol sedation compared with deep sedation. 52 This would further support the idea that minimising the use of GABA-ergic drugs may be appropriate.
Intensive care
In intensive care, a daily review of all drugs should help decrease the risk of delirium in an individual patient. All drugs with anticholinergic properties, including furosemide and Multidisciplinary approach to management of delirium
Risk factor Management plan
Cognitive impairment/disorientation Appropriate lighting, signage, calendar, visible clock; explain where patient is; allow visits from family and friends; avoid moving patients between bays/wards.
Dehydration/constipation
Ensure adequate fluid intake; optimise fluid management.
Hypoxia
Optimise oxygen saturation.
Infection
Identify and treat any infection; avoid unnecessary catheterisation; implement proper infection control.
Immobility
Encourage mobilisation, provide mobility aids, if unable to walk, encourage range of motion exercises.
Pain
Careful assessment includes non-verbal signs; start and review appropriate pain management in those suspected of pain. Both under-treatment of pain and over-treatment with opioids may contribute to development of delirium.
Medications
Review medications and correct for polypharmacy.
Poor nutrition Follow advice on nutrition; ensure dentures are available and well fitting for those who need them.
Sensory impairment
Resolve reversible causes, eg impacted earwax; ensure functional hearing/visual aids available.
Sleep disturbance Promote good sleep pattern; avoid noise and activities (medical procedures/medication rounds) that cause disturbance during sleeping hours.
Mood fluctuation
Observe for behavioural changes daily.
Treatment of distress
If distressed, try verbal de-escalation techniques. If these fail and patient is considered a risk to themselves or others consider short-term haloperidol or olanzapine. Avoid antipsychotic drugs especially in those with Parkinson's disease or dementia with Lewy bodies.
Reassessment
Reassess patient for resolution of delirious episode. 
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digoxin, may precipitate delirium. 53 As a minimum, sedation protocols need to be used in all ventilated critically ill patients, which should include daily sedation targets and daily sedation holds where appropriate. 54 Schweickert demonstrated that early mobilisation of intensive care patients decreases delirium and improves outcomes. 55 All sedative drugs including propofol and fentanyl are likely to precipitate delirium depending on the patient vulnerability, daily dose and duration of exposure. However, although opioids can themselves be a precipitant of delirium, 56 careful use of these analgesics, including methadone for management of pain, is associated with a significantly lower risk of delirium. 27 Studies suggest that clonidine and dexmedetomidine, alpha-2 adrenergic agonists, may be beneficial in terms of achieving length of time at the targeted level of sedation and less agitated delirium. 29 Most psychotropic drugs have been identified as risk factors for precipitating delirium and benzodiazepines, gammaaminobutyric acid (GABA) receptor agonists, should be avoided due to their deliriogenic effects. 57 Indeed, Agarwal et al showed that in critically ill burns patients, benzodiazepines increase the likelihood of developing delirium seven-fold. 27
Pharmacological prophylaxis
The use of atypical antipsychotic drugs has been shown to provide effective prophylaxis against the development of delirium. Olanzapine 5 mg given immediately before and after surgery has been shown to reduce the incidence of delirium in hip-and knee-replacement surgery patients aged over 65 from 40% in the placebo arm to 14% in the treatment arm. 58 Similarly, other studies using the atypical antipsychotics olanzapine or quetiapine with haloperidol have also shown improvement in symptoms and faster resolution of delirium. 59 Trials addressing the use of haloperidol for pharmacological prophylaxis have yielded contrasting results. A large trial of 457 postoperative non-cardiac patients admitted to intensive care in Beijing, demonstrated a reduction in delirium incidence from 23.2% to 15.3% using prophylactic haloperidol compared with placebo. 60 There was a small decrease in ICU stay. However, in a randomised, double-blinded, placebo-controlled study, in which elderly hip-surgery patients were given 0.5 mg haloperidol three times a day starting preoperatively and continuing for three days postoperatively, the severity and duration of delirium (5.4 vs 11.8 days) was reduced but the regimen had no efficacy in reducing the incidence of postoperative delirium. 61 A smaller US pilot study did not show a reduction in ICU delirium using haloperidol or ziprasidone enterally, but was not sufficiently powered. 62 A trial comparing rivastigmine with placebo in delirious critically ill patients was halted early for safety reasons. 63 The mortality and duration of delirium was higher in the rivastigmine group than with placebo. This was not statistically significant but there was enough concern to terminate the trial. The use of anticholinesterases to prevent or manage delirium in critically ill patients is not recommended and may be harmful.
Pharmacological treatment
Haloperidol is the recommended pharmacological treatment of delirium as recommended by the American College of Critical Care and the Society of Critical Care Medicine. 64 Haloperidol or olanzapine are recommended treatments by NICE. Although haloperidol is not licensed to be used intravenously, it is accepted practice in intensive care patients and is used by the majority of UK ICU consultants to treat delirium. 42 Using an antipsychotic drug to manage a patient' s delirium necessitates knowledge of the risks and the subsequent management of those risks up to and including torsades de pointes. 65 Benzodiazepines remain a first line treatment in delirium tremens resulting from alcohol withdrawal. They are not indicated for treatment of delirium from other causes. 66 There is ongoing research to try to address the key question of whether hypoactive delirium, which is so challenging to diagnose, is best managed with non-pharmacological interventions or with antipsychotics. Until the results are known, the authors suggest that non-pharmacological interventions are used in all critically ill patients; further use of antipsychotics is dependent on the judgment of individual clinicians.
Summary and future directions
NICE recommends that cognitive assessment should be completed on hospital admission for example by performing the abbreviated mental test score (AMTS). Routine screening for delirium performed on every shift would facilitate early recognition of the syndrome. This will enable prompt treatment of causes, which if applied appropriately will potentially decrease severity, reduce recurrence, prevent cognitive decline and shorten length of stay.
Increased awareness through training and education in hospitals would generate greater knowledge of delirium, increase appropriate investigations of underlying cause and drive up quality of care for all patients.
More research is needed into the use of antipsychotics whether for prophylaxis or to treat delirium and if so whether their use translates to an improvement in patient outcome.
In summary, it is clear from the literature that, despite much interest and many good quality studies in this field, delirium in hospitals is still a major concern among physicians. Relatives and patients are themselves becoming more aware of the syndrome and its consequences, therefore, it is important that clinicians do all they can to limit both the occurrence and the downstream effects of delirium and realise the importance of simple cognitive testing during admission to hospital.
